Healum CEO Jonathan Abraham was invited to the Health Popup London panel discussion on February 13, 2019
The #Healthpopup London event organised by Mount Sinai group along with Humble ventures at Queensmary University. The event witness lots of healthcare enthusiasts from both the startup sector and the academics & students who were quite passionate about healthcare and the use of technology in countries like the UK and the USA.
Eric Lium and Eric Kostegan from Mount Sinai Co-Labs started the event by astonishing the audience about the opportunities available for UK startups in the United States of America.
The first panel discussion was about commercialising the health-tech in the USA which was moderated by Ritesh Patel from Ogilvy Consultancy. The panelists seemed quite pro-USA as they felt that the pace of commercialising technology in healthcare is faster as opposed to any other countries.
This was followed by another panel discussion on funding health innovations and the challenges and problems involved in the process. Parker Moss, a distinguished entrepreneur and investor at F-Prime ventures and Fidelity, discussed great problems for investors and that most investors never get the money they invested. He also mentioned the importance of maintaining good relations with investors and not just limit it to monetary purposes, as at the end of the day investors are as good as business partners.
This was followed by another panel discussion on impact of machines on healthcare and another one on accelerating uptake of high-impact innovations for patient population and the NHS staff.
The conference ended with a panel discussion by emerging startups in the field of artificial intelligence in healthcare and included representatives from startups like Healum, MySense, HealthUnlocked, Hospify to name a few. Jonathan Abraham, CEO & co-founder Healum said “Healum has begun a journey to develop an AI system that is powered by healthcare professionals from healthcare professionals and for healthcare professionals to ease their concerns about sourcing second opinions for a particular patient treatment and management for a set of conditions, allergies, comorbidities and prescriptions to understand the patient pathway and come up with an easy way to see and analyse the outcomes of the results”
The session concluded with networking and drinks where the startups shared their vision for the technological advancements in healthcare but more importantly improving human lives.